Retina/Vitreous News

LAS VEGAS — Visionix introduced the VX 610 nonmydriatic automated fundus camera to attendees at Vision Expo West.

EyePoint Pharmaceuticals announced that the first patient has been dosed in the global, phase 3 LUGANO clinical trial of Duravyu, formerly EYP-1901, as a treatment for wet age-related macular degeneration, according to a press release.

BARCELONA, Spain — A large amount of real-world data collected from clinics across the U.K. highlighted the effectiveness, safety and durability of faricimab for diabetic macular edema in treatment-naive and previously treated eyes.

CHICAGO — In this Healio Video Perspective from the AAO meeting, David A. Eichenbaum, MD, discusses results from a phase 1 trial investigating axitinib for the treatment of neovascular age-related macular degeneration.

Science Corporation reported positive preliminary results of a clinical trial examining its Prima retinal implant in patients with central visual field loss due to geographic atrophy.

Ocuphire Pharma has acquired Opus Genetics in an all-stock transaction, with the aim of expanding its position in the gene therapy space for the treatment of inherited retinal diseases, according to a press release.

A 92-year-old Asian man was seen in the uveitis ophthalmology clinic due to 2 weeks of bilateral eye injection, pain, tearing and photosensitivity. He denied flashes, floaters, diplopia or metamorphopsia.

CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Douglas Love, president and CEO of Annexon Biosciences, discusses the company’s phase 3 program in geographic atrophy.

In this video, Barbara Blodi, MD, discusses results from the ARCHER trial presented at the American Society of Retina Specialists annual meeting.

CHICAGO — In this Healio Video Perspective from the AAO meeting, Allen C. Ho, MD, of Wills Eye Hospital shares promising results of a phase 2b/3 trial investigating MCO-010 optogenetic therapy for the treatment of retinitis pigmentosa.